| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 79,618,928 | 89,601,281 | 70,513,408 | | Cost of Revenue | 63,945,789 | 68,885,313 | 54,652,433 | | | Gross Profit | 15,673,139 | 20,715,969 | 15,860,975 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 17,366,109 | 17,315,895 | 15,201,630 | | Non Recurring | 394,572 | (382,194) | 49,470 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,087,542) | 3,782,268 | 609,875 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 795,201 | 1,159,137 | 489,303 | | Earnings Before Interest And Taxes | (1,550,964) | 4,941,405 | 1,099,178 | | Interest Expense | 251,073 | 231,603 | 231,863 | | Income Before Tax | (1,802,037) | 4,709,802 | 867,315 | | Income Tax Expense | (749,232) | 2,055,128 | 458,048 | | Minority Interest | 33,743 | 58,368 | (4,038) | | | | Net Income From Continuing Ops | (1,019,061) | 3,731,294 | 1,073,788 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,019,061) | 3,731,294 | 1,073,788 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,019,061) | $3,731,294 | $1,073,788 |
|
0.29% Nasdaq 
Income Statement
